Paul Workman

Affiliations: 
Cancer Therapeutics The Institute of Cancer Research 
Google:
"Paul Workman"
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Sanfelice D, Antolin AA, Crisp A, et al. (2024) The Chemical Probes Portal - 2024: update on this public resource to support best-practice selection and use of small molecules in biomedical research. Nucleic Acids Research
Gingrich PW, Chitsazi R, Biswas A, et al. (2024) canSAR 2024-an update to the public drug discovery knowledgebase. Nucleic Acids Research
Workman P. (2023) The NCI-60 Human Tumor Cell Line Screen: A Catalyst for Progressive Evolution of Models for Discovery and Development of Cancer Drugs. Cancer Research. 83: 3170-3173
Mader MM, Rudolph J, Hartung IV, et al. (2023) Which Small Molecule? Selecting Chemical Probes for Use in Cancer Research and Target Validation. Cancer Discovery. OF1-OF16
Hartung IV, Rudolph J, Mader MM, et al. (2023) Expanding Chemical Probe Space: Quality Criteria for Covalent and Degrader Probes. Journal of Medicinal Chemistry
di Micco P, Antolin AA, Mitsopoulos C, et al. (2023) canSAR: update to the cancer translational research and drug discovery knowledgebase. Nucleic Acids Research. 51: D1212-D1219
Antolin AA, Sanfelice D, Crisp A, et al. (2022) The Chemical Probes Portal: an expert review-based public resource to empower chemical probe assessment, selection and use. Nucleic Acids Research
Müller S, Ackloo S, Al Chawaf A, et al. (2021) Target 2035 - update on the quest for a probe for every protein. Rsc Medicinal Chemistry. 13: 13-21
Hoey R, Sharpe E, Kukula A, et al. (2021) Enhancing access to innovative cancer drugs: Cross-sector consensus on a way forward to benefit patients. Drug Discovery Today. 27: 946-950
Antolin AA, Clarke PA, Collins I, et al. (2021) Evolution of kinase polypharmacology across HSP90 drug discovery. Cell Chemical Biology
See more...